MDSCs and tumor-associated platelets (TAPs) further contribute to breast cancer immune evasion by inhibiting T-cell and NK-cell activity, secreting immunosuppressive cytokines such as IL-10 and TGF-β, and promoting regulatory T-cell expansion. Here, TGFB1 is linked to breast carcinoma.